Acute Kidney Injury after Administering Dapagliflozin to a Diabetic Patient with Acute Cerebral Infarction / 대한내과학회지
Korean Journal of Medicine
;
: 404-408, 2020.
Article
in Korean
| WPRIM
| ID: wpr-894518
ABSTRACT
Dapagliflozin is a recently developed oral anti-diabetic drug and SGLT2 inhibitor with well-known cardioprotective and renoprotective effects. Although a reduction of the glomerular filtration rate is induced by volume depletion and tubule-glomerular feedback during the early period after administering a SGLT2 inhibitor, the renal prognosis improves more with a decrease of proteinuria. However, the risk of acute kidney injury increases in heart failure and hypovolemia patients, and in those taking certain drugs, such as non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers, or diuretics. We report acute kidney injury after dapagliflozin administration in a diabetic patient with acute cerebral infarction accompanied by right hemiplegia, motor aphasia, and dysphagia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS